STEMI mortality remains a primary concern among healthcare providers, and a new study in the American Journal of Cardiology suggests that long-term outcomes are much better if the patient undergoes primary PCI.
The new study, published by the American Journal of Cardiology, suggests that frailty could be a helpful predictor for major bleeding events after PCI.
After two years, TAVR was still linked to a reduction in the study’s primary endpoint, but it was also associated with a greater risk of valve thrombosis.